Constitutive Androstane Receptor

Constitutive Androstane Receptor (CAR) 是一种核受体。CAR 的上游靶点包括蛋白磷酸酶 2A (PP2A)、细胞外信号调节激酶 (ERK)、p38 丝裂原活化蛋白激酶 (MAPK)、表皮生长因子受体 (EGFR)以及多种转录因子如肝细胞核因子 4α (HNF4α) 等。PP2A 参与 CAR 的去磷酸化,促进其核转位;ERK 和 MAPK 通过影响 CAR 的磷酸化状态调节其活性;EGFR 可间接调节 CAR 的激活;转录因子则调控 CAR 的表达水平。CAR 的下游热门靶点有众多药物代谢酶和转运体基因,如细胞色素 P450 酶系 (CYP) 中的 CYP2B6、CYP3A4 等,以及能量代谢相关基因如脂生成基因和糖异生相关基因。CAR 激活可改善胰岛素敏感性,缓解肥胖和 2 型糖尿病症状;但同时,其异常激活也可能与肝肿瘤的发生发展有关。CAR 在药物代谢、能量代谢、肥胖、2 型糖尿病和癌症发展等过程中发挥关键作用[1][2][3][4][5][6]。

Constitutive Androstane Receptor (CAR) is a nuclear receptor. The upstream targets of CAR include protein phosphatase 2A (PP2A), extracellular signal-regulated kinase (ERK), p38 mitogen-activated protein kinase (MAPK), epidermal growth factor receptor (EGFR), and various transcription factors such as hepatocyte nuclear factor 4α (HNF4α). PP2A participates in the dephosphorylation of CAR and promotes its nuclear translocation; ERK and MAPK regulate the activity of CAR by affecting its phosphorylation state; EGFR can indirectly regulate the activation of CAR; and transcription factors regulate the expression level of CAR. The downstream hot targets of CAR include many drug metabolizing enzymes and transporter genes, such as CYP2B6 and CYP3A4 in the cytochrome P450 enzyme system (CYP), as well as energy metabolism-related genes such as lipogenesis genes and gluconeogenesis-related genes. CAR activation can improve insulin sensitivity and alleviate the symptoms of obesity and type 2 diabetes; however, its abnormal activation may also be associated with the occurrence and development of liver tumors. CAR plays a key role in drug metabolism, energy metabolism, obesity, type 2 diabetes, and cancer development[1][2][3][4][5][6].

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
5α-Androstan-3α-ol
3α,5α-Androstanol

5α-Androstan-3α-ol 是一种γ-氨基丁酸 (GABA) 受体激动剂,能够抑制孤儿核受体 CAR (组成型雄烷受体) 的转录活性,并通过结合 CAR 及促进其与共激活蛋白解离来负调控 CAR 的活性,可用于研究核受体介导的激素代谢和药物解毒机制。

7657-50-3
Inhibitor
5α-Androstan-3α-ol
S07662

S07662 是一种人组成型雄甾烷受体 (hCAR) 抑制剂,IC50 为 0.7 μM,在细胞基础实验中可募集辅助抑制因子 NCoR,并减弱苯妥英 (MS-C17934) 和 CITCO (MS-N90393) 诱导的人原代肝细胞中 CYP2B6 mRNA 的表达。

883226-64-0
Inhibitor
S07662

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础